Development
Recursion Pharmaceuticals, Inc.
RXRX
$5.49
$0.9220.13%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.79% | -14.81% | -21.26% | -19.96% | 6.46% |
| Total Receivables | 12.39% | -72.81% | -73.88% | -81.95% | -69.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 153.53% | 30.64% | 17.05% | -0.18% | 89.16% |
| Total Current Assets | -23.11% | -14.76% | -21.06% | -20.56% | 6.56% |
|
|
|||||
| Total Current Assets | -23.11% | -14.76% | -21.06% | -20.56% | 6.56% |
| Net Property, Plant & Equipment | -1.05% | 0.68% | 7.33% | 20.30% | 87.64% |
| Long-term Investments | 6,398.88% | 6,485.52% | 7,455.06% | 0.00% | 0.00% |
| Goodwill | 6,398.88% | 6,485.52% | 7,455.06% | 0.00% | 0.00% |
| Total Other Intangibles | 2,690.43% | 2,608.24% | 3,367.72% | 0.69% | -5.70% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.01% | -4.54% | -7.14% | -8.54% | -9.13% |
| Total Assets | -6.79% | 3.15% | -0.86% | -14.56% | 14.90% |
|
|
|||||
| Total Accounts Payable | -13.80% | 9.64% | -34.32% | 2.04% | 62.68% |
| Total Accrued Expenses | 37.90% | -29.33% | 62.84% | 28.10% | 9.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.79% | 7.35% | 10.50% | 22.09% | 6,621.11% |
| Total Finance Division Other Current Liabilities | -30.41% | 36.15% | 7.58% | -0.10% | 269.04% |
| Total Other Current Liabilities | -30.41% | 36.15% | 7.58% | -0.10% | 269.04% |
| Total Current Liabilities | -7.08% | 13.35% | 17.91% | 7.52% | 114.89% |
|
|
|||||
| Total Current Liabilities | -7.08% | 13.35% | 17.91% | 7.52% | 114.89% |
| Long-Term Debt | 105.41% | 100.71% | 97.10% | 93.28% | -15.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.26% | -3.68% | -4.01% | -1.15% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -25.17% | -43.23% | -59.11% | -46.70% | 249.28% |
| Total Liabilities | -11.70% | -13.71% | -15.83% | -18.09% | 219.67% |
|
|
|||||
| Common Stock & APIC | 27.16% | 35.31% | 30.35% | 19.49% | 19.32% |
| Retained Earnings | -51.30% | -50.26% | -49.84% | -54.56% | -59.86% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -4.60% | 12.87% | 7.17% | -12.84% | -10.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -4.60% | 12.87% | 7.17% | -12.84% | -10.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.60% | 12.87% | 7.17% | -12.84% | -10.52% |
|
|
|||||